Skip to content

Seth N. Braunstein, MD

NPI 1427080720ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Wilmington, NC

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Wilmington, North Carolina, trained at New York University School of Medicine (class of 1972). Their prescriptions cost Medicare Part D more than their services did: $2,919,221 for 7,067 claims, against $178,711 paid for services in 2024. Novo Nordisk Inc was the largest of 34 companies reporting payments in 2025, $2,768 in all, mostly food and beverage.

Overview

NPI1427080720
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 7, 2006
Last updated in NPPESJan 17, 2020
Certified by providerJan 17, 2020

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary207RE0101X2011-01745NC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NC)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients358
Services billed8,875 across 63 procedure codes
Paid by Medicare$178,711

Part D prescriptions in 2024

Prescriptions (claims)7,067 · 15,851 30-day fills
Patients614
Total drug cost$2,919,221
Generic share42% of claims

Medicare sources and data years

Education and affiliations

Medical schoolNew York University School of Medicine
Graduation year1972
Medicare specialtyEndocrinology

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$2,768 · 145 payments from 34 companies
  • 2024$2,622 · 150 payments from 26 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$372.3319
Lilly USA, LLC$285.6016
Amgen Inc.$234.2817
Antares Pharma, Inc.$231.9610
Abbott Laboratories$191.2213

What the 2025 payments were for

  • Food and Beverage$2,725 · 144 payments
  • Education$42.50 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Wilmington

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in North Carolina →